The Rwanda Malaria Strategic Plan 2020–2024 outlines Rwanda’s national strategy to reduce malaria morbidity and mortality by at least 50% compared to 2019 levels. The vision is a malaria-free Rwanda contributing to socioeconomic development.
The plan includes strengthening prevention through lo...ng-lasting insecticide-treated nets, indoor residual spraying, and larval source management; ensuring universal access to testing and treatment; improving surveillance and data use; and enhancing program management, coordination, and financing. It also emphasizes community engagement and behavior change to ensure at least 85% of the at-risk population adopts protective practices.
The strategy builds on past lessons, involves multi-sectoral collaboration, and aligns with global malaria goals. It highlights equity, quality services, and evidence-based interventions as guiding principles, aiming to mobilize national and international resources for sustained impact.
more
PHSM are vital in reducing the risk and scale of infectious disease transmission and lowering hospitalization and deaths. Examples include contact tracing, quarantine and isolation, mask use, ventilation, school or workplace measures, mobility restrictions and travel requirements.
While these mea...sures are essential, decision-making on PHSM becomes particularly complex during rapidly evolving health emergencies, with incomplete information and under significant public and political pressure, especially when the pathogen is novel or poorly understood. In such contexts, guidance needs to be agile and responsive, developed and adapted based on emerging evidence and shifting epidemiological patterns. Decision-makers are frequently confronted with difficult trade-offs, having to balance measures that are:
─ effective but socially disruptive;
─ cost-effective but logistically burdensome;
─ beneficial for public health but economically disruptive; or
─ practical but inequitable or unethical
more
Этот документ, содержащий ответы на часто задаваемые вопросы, дополняет временные рекомендации ВОЗ «Клиническое руководство по ведению пациентов с тяжелой остро... респираторной инфекцией при подозрении на инфицирование новым коронавирусом» и посвящен вопросам в связи с этими рекомендациями.
Во временных рекомендациях и настоящем документе отражены:
i. имеющиеся сведения в отношении риска заражения COVID19 через грудное молоко;
ii. сведения о благотворном воздействии грудного вскармливания и контакта «кожа к коже»;
iii. сведения о неблагоприятном воздействии детских молочных смесей в случае неправильного
использования.
COVID-19 and breastfeeding (frequently asked questions)
more
Do I really need antibiotics? - Fact Sheet for Patients
Scientific Brief, 17 June 2021
Guide to access the National AMR Surveillance Dashboard
Available in Arabic, Chinese, English, French, Portuguese and Spanish
https://apps.who.int/iris/handle/10665/334254